Skip to content
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Breast Surgery

Does Breast Fibrosis Go Away? What to Expect Over Time

At a Glance

Breast fibrosis does not have one predictable course: hormonal and fibrocystic symptoms may fluctuate or improve after menopause, while established surgical-scar and radiation fibrosis often persist. Any new, growing, or changing breast finding needs medical assessment.

The short answer is that it depends on the cause of the fibrosis. Some symptoms related to hormonal changes can fluctuate, while established scar tissue or radiation fibrosis is often permanent.

“Breast fibrosis” is a general term for a buildup of fibrous, supportive connective tissue. Its long-term behavior depends directly on what caused it. Many benign (noncancerous) fibrotic findings are stable over time, but benign areas can sometimes change or mimic cancer on imaging [1][2]. Any new or persistent change should always be medically assessed.

Summary of Breast Fibrosis Types

Cause Typical Pattern Over Time When to Seek Care
Hormonal / Fibrocystic Symptoms (pain, lumpiness) fluctuate with cycles; often improve after menopause. New, hard, distinct lump; spontaneous nipple discharge.
Idiopathic Stromal Usually stable or slowly becomes smaller if confirmed benign. Interval growth or a change that doesn’t match imaging.
Surgical Scar Persists permanently but may soften or remodel over the first 1–2 years. A new lump near the scar; new skin dimpling.
Radiation Develops months to years later; typically permanent but can stabilize. Rapidly worsening swelling, new skin redness or thickening.
Diabetic Mastopathy Variable: can be stable, shrink, or recur in other areas. Any new hard mass (never assume it’s just from diabetes).

Hormonal and Fibrocystic Changes

Fibrocystic changes are very common and are influenced by the hormonal fluctuations of your menstrual cycle [3][4]. If your symptoms are part of a fibrocystic breast condition, you may feel firm, nodular areas and tenderness that wax and wane throughout the month. Over time, particularly after menopause, these symptoms often regress (shrink or go away entirely) or remain stable [5]. Keep in mind that while the general lumpiness and pain can fluctuate, a specific area of focal fibrosis may persist.

Idiopathic Stromal Fibrosis

Idiopathic stromal fibrosis refers to focal areas of fibrous stromal tissue (the breast’s supporting tissue) without a known cause (idiopathic means “unknown cause”). When these areas are biopsied and confirmed to be benign stromal fibrosis, they usually remain stable in size or slowly become smaller over time [6].

However, a benign biopsy result is only reassuring if the pathology matches the imaging findings—a concept doctors call radiology-pathology concordance [2]. If a fibrotic area grows or looks suspicious on imaging, repeat biopsy or surgical removal may be needed to ensure no cancer is hiding within it [7][8].

Post-Procedure and Surgical Scars

When breast tissue is injured—whether from a biopsy, lumpectomy, or trauma—the body heals. This healing response can include temporary bruising, fat necrosis (damaged fat cells), or permanent scar tissue (fibrosis). Surgical scars typically persist permanently, though they may soften and remodel over the first year or two after the procedure [9].

Scars do not cause cancer, but scar tissue can make mammograms more difficult to read, and a new cancer or recurrence can sometimes develop independently in the same area [1]. A new or changing lump should not be assumed to be just scar tissue.

Radiation-Induced Fibrosis

If you have received radiation therapy for breast cancer, radiation-induced fibrosis is a common late effect that can develop months or years after treatment [10][11]. The radiation causes the breast tissue to become firmer, which can lead to breast retraction (the breast or skin pulling inward), asymmetry, and sometimes pain [12].

Unlike hormonal changes, radiation fibrosis is generally permanent [13]. While there may be some improvement over time with individualized symptom management, established radiation fibrosis is not reliably reversible [14][15]. Importantly, any new or progressively worsening skin thickening, redness, or swelling years after radiation should be evaluated promptly by your doctor, rather than assumed to be radiation fibrosis [16][17].

Diabetic Mastopathy

Diabetic mastopathy is an uncommon condition typically found in people with long-standing type 1 diabetes (though it can occur in others with diabetes). It causes hard, painless masses of fibrous tissue that can feel very similar to breast cancer on examination and imaging [18].

The natural history is variable: lesions may remain stable, shrink, or recur in different areas (even in the opposite breast) years later [19][20]. Because it mimics cancer so closely, a hard mass should never be ignored simply because you have diabetes; it requires proper diagnostic evaluation, often including a core needle biopsy [21].

When to Seek Reassessment

While many benign fibrotic findings remain stable, follow-up depends on your specific diagnosis, symptoms, and whether your imaging matches your biopsy results. If you still menstruate, you can track whether changes follow your cycle; if you are postmenopausal or have suppressed cycles, any new change should be reported.

Contact your care team promptly if you experience:

  • Interval growth: A known lump that gets larger or feels noticeably harder over time [7].
  • Skin changes: Rapidly worsening or new skin dimpling, thickening, redness, or edema (swelling caused by fluid) [16]. If redness and warmth are accompanied by a fever after a procedure, seek same-day medical advice as this may indicate an infection.
  • Nipple changes: New nipple inversion (pulling inward) or spontaneous, single-duct, bloody or clear nipple discharge [22].
  • Axillary swelling: Enlarged lymph nodes in your axillary (underarm) area [23].
  • Persistent focal pain: Pain alone is rarely the only sign of cancer, but persistent, severe pain in one specific spot that does not fluctuate deserves review [24].

If a known fibrotic area changes, your doctor will review your imaging, ensure concordance, and recommend the best next steps [25].

Common questions in this guide

Can benign breast fibrosis disappear on its own?
It depends on the type. Hormonal or fibrocystic symptoms may fluctuate and often improve after menopause, while a focal area of fibrosis can remain. Confirmed benign stromal fibrosis is usually stable or slowly becomes smaller, but it should still be followed as recommended.
Is scar tissue after breast surgery permanent?
A surgical scar usually remains, although it may soften and remodel during the first one to two years after a procedure. A new or changing lump near the scar should be assessed rather than automatically attributed to scar tissue.
Will breast radiation fibrosis go away?
Radiation fibrosis is generally permanent and may appear months or years after radiation treatment. Individualized care may ease tightness or pain, but established fibrosis is not reliably reversible. New or worsening redness, skin thickening, or swelling should be checked promptly.
Can diabetic mastopathy shrink or come back?
Diabetic mastopathy may remain stable, shrink, or recur in another area, including the opposite breast. Because it can feel and look like breast cancer, any hard mass needs proper evaluation and may require a core needle biopsy.
When should a fibrotic breast area be checked again?
Arrange medical review if the area grows, becomes harder, or is accompanied by skin dimpling, thickening, redness, swelling, nipple inversion, spontaneous discharge, or underarm swelling. Persistent, severe pain in one spot also deserves review, and redness or warmth with fever after a procedure needs same-day medical advice.
What does stromal fibrosis on a breast biopsy mean?
Stromal fibrosis means the biopsy found benign fibrous supporting tissue. The result is reassuring when it matches the imaging findings; if the area grows or remains suspicious, your clinician may recommend repeat biopsy or surgical removal.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my biopsy or imaging results, is my specific type of breast fibrosis concordant with the imaging?
  2. 2.Given my type of fibrosis, what symptoms or changes should make me call your office sooner than my scheduled follow-up?
  3. 3.Do I need a specific specialist (like a breast surgeon or radiation oncologist) involved in my monitoring?
  4. 4.If I experience tenderness, tightness, or pain from my scar or radiation fibrosis, what individualized symptom management options do we have?
  5. 5.How can we ensure that this firm area doesn't hide a new issue on my future mammograms?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    Ultrasound-guided vacuum-assisted breast biopsy in the diagnosis of cancer recurrence at the surgical scar: a report of three cases.

    Tahoun LA, Maraqa B

    Journal of ultrasonography 2022; (22(88)):e57-e63 doi:10.15557/JoU.2022.0010.

    PMID: 35449697
  2. 2

    Stromal fibrosis: imaging features with diagnostic contribution of diffusion-weighted MRI.

    Yilmaz R, Bayramoglu Z, Kartal MG, et al.

    The British journal of radiology 2018; (91(1085)):20170706 doi:10.1259/bjr.20170706.

    PMID: 29388800
  3. 3

    THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA.

    Brkić M, Vujović S, Ivović M, et al.

    Acta clinica Croatica 2018; (57(4)):756-761 doi:10.20471/acc.2018.57.04.18.

    PMID: 31168213
  4. 4

    Clinicopathological profile of mastalgia in females: incidence, types, and pathological correlations. a cross-Sectional study.

    Ali AA, Faraj FH

    Annals of medicine and surgery (2012) 2023; (85(10)):4764-4772 doi:10.1097/MS9.0000000000001159.

    PMID: 37811083
  5. 5

    Pure Fibrocystic Change Diagnosed at MRI-guided Vacuum-assisted Breast Biopsy: Imaging Features and Follow-up Outcomes.

    Chen ST, Okamoto S, Daniel BL, et al.

    Journal of breast imaging 2020; (2(2)):141-146 doi:10.1093/jbi/wbz090.

    PMID: 38424890
  6. 6

    Stromal Fibrosis of the Breast: A Spectrum of Benign to Malignant Imaging Appearances.

    Nassar L, Baassiri A, Salah F, et al.

    Radiology research and practice 2019; (2019()):5045908 doi:10.1155/2019/5045908.

    PMID: 30886748
  7. 7

    Benign Breast Tumours - Diagnosis and Management.

    Paepke S, Metz S, Brea Salvago A, Ohlinger R

    Breast care (Basel, Switzerland) 2018; (13(6)):403-412 doi:10.1159/000495919.

    PMID: 30800034
  8. 8

    Fibromatosis-Like Metaplastic Carcinoma of the Breast: A Challenging Diagnosis With Potential Pitfalls.

    Laokulrath N, Gudi MA, Tan PH, et al.

    International journal of surgical pathology 2025; (33(5)):1224-1229 doi:10.1177/10668969241300498.

    PMID: 39692324
  9. 9

    Beyond the lung: recognizing incidental breast lesions on chest computed tomography.

    Gil BM, Cha YK, Park H, et al.

    Translational cancer research 2026; (15(3)):215 doi:10.21037/tcr-2025-1-2779.

    PMID: 41969517
  10. 10

    Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.

    Azria D, Riou O, Castan F, et al.

    EBioMedicine 2015; (2(12)):1965-73 doi:10.1016/j.ebiom.2015.10.024.

    PMID: 26844275
  11. 11

    Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

    Grossberg AJ, Lei X, Xu T, et al.

    JAMA oncology 2018; (4(12)):1751-1757 doi:10.1001/jamaoncol.2018.2583.

    PMID: 30027292
  12. 12

    The association between breast fibrosis, cosmetic outcomes, and long-term health-related quality of life after breast-conserving therapy: a multicenter cross-sectional observational cohort study.

    Notenboom MCAW, Klem TMAL, Contant CME, et al.

    Breast (Edinburgh, Scotland) 2025; (83()):104541 doi:10.1016/j.breast.2025.104541.

    PMID: 40774221
  13. 13

    Association of CD4+ Radiation-Induced Lymphocyte Apoptosis with Fibrosis and Telangiectasia after Radiotherapy in 272 Breast Cancer Patients with >10-Year Follow-up.

    Veldwijk MR, Seibold P, Botma A, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2019; (25(2)):562-572 doi:10.1158/1078-0432.CCR-18-0777.

    PMID: 30327309
  14. 14

    Hyperbaric oxygen therapy for local late radiation toxicity in breast cancer patients: A systematic review.

    Meier EL, Mink van der Molen DR, Lansdorp CA, et al.

    Breast (Edinburgh, Scotland) 2023; (67()):46-54 doi:10.1016/j.breast.2022.12.009.

    PMID: 36587606
  15. 15

    Effect of hyperbaric oxygen treatment on skin elasticity in irradiated patients.

    Pandey K, Teguh DN, van Hulst RA

    Diving and hyperbaric medicine 2022; (52(3)):208-212 doi:10.28920/dhm52.3.208-212.

    PMID: 36100932
  16. 16

    Radiation-induced angiosarcoma of the breast: a retrospective analysis of 15 years' experience at an oncology center.

    Alves I, Marques JC

    Radiologia brasileira 2018; (51(5)):281-286 doi:10.1590/0100-3984.2017.0129.

    PMID: 30369653
  17. 17

    Breast Angiosarcoma: Imaging Features With Histopathologic Correlation.

    Kapoor MM, Yoon EC, Yang WT, Patel MM

    Journal of breast imaging 2023; (5(3)):329-338 doi:10.1093/jbi/wbac098.

    PMID: 38416884
  18. 18

    Diabetic mastopathy: imaging features and the role of image-guided biopsy in its diagnosis.

    Kim J, Kim EK, Kim MJ, et al.

    Ultrasonography (Seoul, Korea) 2016; (35(2)):140-7 doi:10.14366/usg.15052.

    PMID: 26810194
  19. 19

    Ultrasound as a Valuable Imaging Modality in Sclerosing Lymphocytic Lobulitis: Imaging Features Based on a Retrospective Cohort Analysis of 51 Cases.

    Sato LT, de Mello GGN, Stiepcich MMA, et al.

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2021; (72(4)):767-774 doi:10.1177/0846537120983122.

    PMID: 33461324
  20. 20

    Metachronous bilateral diabetic mastopathy mimicking breast cancer in a woman with long-standing type 2 diabetes: a case report.

    Kuang Z, Ding W, Li L

    Frontiers in medicine 2026; (13()):1957813 doi:10.3389/fmed.2026.1957813.

    PMID: 42755460
  21. 21

    Diabetic Fibrous Mastopathy: Imaging Features With Histopathologic Correlation.

    Patel PB, Carter GJ, Berg WA

    Journal of breast imaging 2023; (5(5)):585-590 doi:10.1093/jbi/wbad033.

    PMID: 38416913
  22. 22

    Benign Breast Disease.

    Pleasant V

    Clinical obstetrics and gynecology 2022; (65(3)):448-460 doi:10.1097/GRF.0000000000000719.

    PMID: 35708970
  23. 23

    Localized amyloidosis: A diagnostic pitfall in breast pathology.

    Lytle A, Darvishian F, Ozerdem U

    Pathology, research and practice 2019; (215(12)):152699 doi:10.1016/j.prp.2019.152699.

    PMID: 31708371
  24. 24

    Management of breast complaints and high-risk lesions.

    Pleasant V

    Best practice & research. Clinical obstetrics & gynaecology 2022; (83()):46-59 doi:10.1016/j.bpobgyn.2022.03.017.

    PMID: 35570155
  25. 25

    From Dyspnea to Suspected Breast Cancer: A Post-traumatic Hematoma as a Diagnostic Pitfall.

    Cohen O, Carême N, Van Steen R, et al.

    Cureus 2026; (18(8)):e114280 doi:10.7759/cureus.114280.

    PMID: 42719434

This page explains how different types of breast fibrosis may change over time for informational purposes only and does not constitute medical advice. Ask your clinician to evaluate any new, persistent, or changing breast symptom.

Get notified when new evidence is published on breast fibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.